NSECopy of Newspaper Publication4d ago · 16 Aug 2026, 09:06 am
Copy of Newspaper Publication
Natco Pharma Limited · NATCOPHARM
✦ AI SummaryResults
Natco Pharma Limited has published un-audited financial results for the quarter ended June 30, 2026, and declared an interim dividend for the FY ending 2026-27.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication for the Un-Audited Financial Results for the quarter ended June 30, 2026 and declaration of Interim Dividend for the FY ending 2026-27.
Attachments (1)
📄pdf
Download →
NATCOPHARM_16082026090553_Q1202627PaperPublications.pdf
View document text
August 16, 2026
Corporate Relationship Department Manager – Listing
M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd
Mumbai 400 001 Mumbai 400 051
Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir / Madam
Sub: - Paper Publications
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time, please find enclosed the copies of the
newspaper Publications as appeared on August 15, 2026 in Business Line, Financial
Express and Nava Telangana regarding the Un-audited Financial Results of the Company
for the quarter ended June 30, 2026 and declaration of Interim Dividend for FY ending
2026-27.
The above publications are available on the website of the Company at
www.natcopharma.co.in
Thanking you
Yours faithfully
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer
Encl: as above